Hyperrab 300 unit/ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB25FKMJZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,372
Award facts
- Contract value 100% obligated
- $5,372.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for HYPERRAB 300 Unit/mL vial 5mL, a rabies immunoglobulin product, with a ceiling value of $5,372.40. This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors and healthcare solutions providers, regularly fulfills federal medical procurement requirements through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military health services worldwide. This specific delivery order for rabies immunoglobulin reflects the company's critical role in supplying specialized pharmaceutical products and vaccines to support Defense Health Agency operations and other federal healthcare systems. All of AmerisourceBergen's reviewed contract awards have been competitively awarded without set-aside designations, demonstrating the company's capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DB25FKMJZ?
SPE2DB25FKMJZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 16, 2025.
How much is contract SPE2DB25FKMJZ worth?
The government has obligated $5,372 on SPE2DB25FKMJZ.
Is contract SPE2DB25FKMJZ an order under another contract?
Yes. SPE2DB25FKMJZ is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMJZ competed?
The extent of competition for SPE2DB25FKMJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award